Does 5-ALA Fluorescence Microscopy Improve Complete Resectability in Cerebral/Cerebellar Metastatic Surgery? A Retrospective Data Analysis from a Cranial Center

被引:1
|
作者
Sarkis, Hraq Mourad [1 ,2 ,3 ]
Alsofy, Samer Zawy [1 ,2 ]
Stroop, Ralf [1 ]
Lewitz, Marc [1 ,2 ]
Schipmann, Stephanie [4 ]
Unnewehr, Markus [1 ]
Paulus, Werner [5 ]
Nakamura, Makoto [6 ]
Ewelt, Christian [2 ]
机构
[1] Witten Herdecke Univ, Fac Hlth, Dept Med, D-58448 Witten, Germany
[2] Univ Munster, St Barbara Hosp, Acad Hosp Westfael Wilhelms, Dept Neurosurg, D-59073 Hamm, Germany
[3] Hannover Med Sch, St Marien Hosp, Acad Hosp, Dept Neurosurg, D-49076 Osnabruck, Germany
[4] Univ Hosp Muenster, Dept Neurosurg, D-48149 Munster, Germany
[5] Univ Hosp Muenster, Inst Neuropathol, D-48149 Munster, Germany
[6] Witten Herdecke Univ, Acad Hosp Koeln Merheim, Dept Neurosurg, D-51109 Cologne, Germany
关键词
5-aminolevulinic acid (5-ALA); fluorescence; metastatic brain tumors; malignant gliomas; protoporphyrin IX; 5-AMINOLEVULINIC ACID; BRAIN METASTASES; PROTOPORPHYRIN-IX; LOCAL RECURRENCE; DIAGNOSIS; RESECTION; CANCER; EPIDEMIOLOGY; MANAGEMENT; LESIONS;
D O I
10.3390/cancers16122242
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary In the present study, the intraoperative fluorescence of brain metastases after the administration of 5-aminolevulinic acid (5-ALA) is investigated in 80 cases. Brain metastases fluoresced in 57.5% of cases, with no significant correlation between fluorescence and primary tumor or histological subtype. Complete resection of brain metastases was detected in 82.5%, of which 56.1% were fluorescence positive, compared to 43.9% which were non-fluorescent. Thus, prior administration of 5-ALA tended to improve the resectability rate by 12.1%. Fluorescence-positive and -negative metastases showed significantly different overall survival in this study. Therefore, administration of 5-ALA as a surgical adjuvant may be beneficial in resecting brain metastases and may potentially optimize the surgical procedure.Abstract (1) Background: In this study, the intraoperative fluorescence behavior of brain metastases after the administration of 5-aminolevulinic acid (5-ALA) was analyzed. The aim was to investigate whether the resection of brain metastases using 5-ALA fluorescence also leads to a more complete resections and thus to a prolongation of survival; (2) Methods: The following variables have been considered: age, sex, number of metastases, localization, involvement of eloquent area, correlation between fluorescence and primary tumor/subtype, resection, and survival time. The influence on the degree of resection was determined with a control MRI within the first three postoperative days; (3) Results: Brain metastases fluoresced in 57.5% of cases. The highest fluorescence rates of 73.3% were found in breast carcinoma metastases and the histologic subtype adenocarcinoma (68.1%). No correlation between fluorescence behavior and localization, primary tumor, or histological subtype was found. Complete resection was detected in 82.5%, of which 56.1% were fluorescence positive. There was a trend towards improved resectability (increase of 12.1%) and a significantly longer survival time (p = 0.009) in the fluorescence-positive group; (4) Conclusions: 5-ALA-assisted extirpation leads to a more complete resection and longer survival and can therefore represent a low-risk addition to modern surgery for brain metastases.
引用
收藏
页数:18
相关论文
empty
未找到相关数据